WEBINARS AND VIDEOS

• Elite Learning Series: Solve Clinical Trial Enrollment Struggles With Better Utilization Of Healthcare Data

  This webinar will feature industry leaders from the U.S. Food and Drug Administration (FDA), Freenome, Cerner Enviza, Deep Lens, and Elligo Health Research®. The discussion will also explore potential pitfalls of healthcare data as well as solutions and strategies for overcoming them.

• Revolutionizing Outsourcing By Starting With The Patient

  During this presentation, learn how a patient-first approach that maintains the trusted physician/patient relationship is the way to access the 97% of patients that have never been involved in a clinical trial.

• Utilizing Cutting-Edge Technologies To Increase Clinical Trial Access And Drive Faster Enrollment

  In an industry notoriously resistant to systemic change, there are many opportunities to employ emerging technologies — to the great benefit of patients and research teams alike.

• Leveraging EHRs And Community Practices To Accelerate Patient-Focused Decentralized Clinical Trials

  Elligo’s Chief Scientific Officer Rebecca Kush, Ph.D., discusses leveraging EHRs and community practices to accelerate patient-focused decentralized clinical trials.

• Revolutionizing Clinical Research To Accelerate Trial Enrollment 10x

  Elligo’s decentralized trial process accesses 150+ million patients and their EHR data to identify qualified patients and bring on as many healthcare providers as needed to accelerate enrollment and execute studies 10x faster than anyone else.

• Streamline Health Research Studies With This Powerful Data Technology

  IntElligo® Research Stack technology is the only system designed to work in a real-world healthcare environment, collecting data at the point of care using CDISC global research data standards and automatically preparing it for regulatory compliance and submission.

• Understanding And Actualizing DCTs, SDR, And SOAR: Toward A New Paradigm For Research In A Changing World

  Decentralized clinical trials (DCTs), which were encouraged by the FDA as a means to modernize clinical trials per the 21st Century Cures Act, have received new interest during the pandemic. Consideration for safety of study participants and clinicians in this changing world demands a new paradigm for research. In this webinar you will learn more about the characteristics of DCTs and hybrid trials, a spectrum of approaches to DCTs, SDR and how it aligns with risk-based monitoring and differs from source data verification (SDV), and opportunities to leverage eSource technology.

• Continuing Clinical Research Innovations After COVID-19

  The COVID-19 pandemic has made the benefits of decentralized or hybrid trial models even more obvious, and as travel restrictions, social distancing and the overall strain on the healthcare system became more evident, the FDA updated regulations to fast-track research, openly recognizing the value of alternative technology such as virtual trial capabilities in clinical research. This webinar will explore how COVID-19 pushed the industry to adapt to tech-enabled solutions for patients and sponsors.

• Clinical Research As Care For Patients

  New treatment options can only become realities when clinical trials are fully enrolled. Learn how Elligo is improving access to clinical trials for patients by bringing research as care options to their physician’s office.